Allergen-specific immunotherapy practices and course of coronavirus disease 2019 (COVID-19) in patients during COVID-19.
Merve ErkoçBetül Özdel ÖztürkDilşad MunganDerya GokmenSevim BavbekYavuz Selim DemirelÖmür AydinBetül Ayşe SinPublished in: Asia Pacific allergy (2022)
COVID-19 pandemic has reduced compliance to AIT. Compliance was higher in venom immunotherapy than in aeroallergens. Severe COVID-19 infection and COVID-19 related death were not observed in patients receiving AIT.